E-ISSN 2231-3206 | ISSN 2320-4672

2020, Vol:10,Issue:1

Research Articles
  • Natl J Physiol Pharm Pharmacol.2020; Volume:10(1):15-20 doi : 10.5455/njppp.2020.10.1034419102019
  • Evaluation of drug of anticancer drugs in oncology department of a tertiary care teaching hospital of Southern Rajasthan
  • Sandeep Kumar Kamlekar , Ankit Agarwal , Aasha Latha P , Sangita Gupta

Abstract

Background: Cancer becomes major health burden on society, increased mortality rate in developing and developed countries. Chemotherapy plays a key role in the management of cancer. Drug utilization studies give an idea about the prescribing practice and characterize the early signals of irrational drug use. Aims and
Objective: The present study was designed to investigate the utilization pattern of anticancer drugs and incidence of cancer types at Oncology Department, Geetanjali Medical College and Hospital, Udaipur, Rajasthan.
Materials and Methods: One ninety two prescriptions of cancer effected patients were screened for anticancer drugs and supportive medications from February 1, 2019, to September 30, 2019, according to disease type, respectively.
Results: In our study, maximum cancer encountering age in both males and females was above 50 years, females are more predominant over males (female 53.64% vs. 46.35% males) with carcinoma of breast 15% followed by carcinoma of ovary 13% with carcinoma of lung 10% in males. Carboplatin 52.08% was the most commonly prescribed drug, followed by paclitaxel 45.31% and gemcitabine 33.85% along with adjuvants dexamethasone 100%, ranitidine 100%, and pantoprazole 35.93% successfully. Conclusion: Carboplatin with other anticancer drugs was a safer combination for treating above-mentioned carcinomas.